Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pancreatitis

Free Subscription Articles published in Surgery Retrieve available abstracts of 146 articles: HTML format

Single Articles

September 2025
1. ZYROMSKI NJ
   Invited editorial regarding "Predicting textbook outcome after pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm: An international validation cohort study".
   Surgery. 2025 Sep 13:109731. doi: 10.1016/j.surg.2025.109731.
   PubMed    
   
   
   
2. LEONHARDT CS, Narbekovas K, Qadan M, Sahora K, et al
   Prognostic factors for very early recurrence after neoadjuvant treatment and curative resection in pancreatic ductal adenocarcinoma.
   Surgery. 2025;187:109647.
   PubMed     Abstract available
   
   
   August 2025
3. ZHANG Z, Zhao X, Zhu H, Jin L, et al
   Predicting textbook outcome after pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm: An international validation cohort study.
   Surgery. 2025 Aug 29:109656. doi: 10.1016/j.surg.2025.109656.
   PubMed     Abstract available
   
   
   
4. CAMPBELL BA, Habib JR, Kinny-Koster B, Purchla J, et al
   The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma.
   Surgery. 2025;187:109611.
   PubMed     Abstract available
   
   
   
5. TAMBURRINO D, Guarneri G, Provinciali L, Vanella G, et al
   Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy.
   Surgery. 2025;186:109594.
   PubMed     Abstract available
   
   
   
6. SEKI Y, Ishizawa T, Mitsuhashi K, Inagaki NF, et al
   Mechanisms of histopathologic vascular damage caused by pancreatic juice leakage: Implications for preventing hemorrhagic complications.
   Surgery. 2025;186:109591.
   PubMed     Abstract available
   
   
   July 2025
7. LANCELLOTTI F
   Response to Letter to the editor: "The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma".
   Surgery. 2025 Jul 17:109551. doi: 10.1016/j.surg.2025.109551.
   PubMed    
   
   
   
8. RAJAONARISON H, Regenet N, Dokmak S, Truant S, et al
   Management of refractory chyle leak after pancreatic surgery: Results from a French national survey on practices and a multicentric study on therapeutic lymphangiography.
   Surgery. 2025;186:109541.
   PubMed     Abstract available
   
   
   
9. MCKEAN JA, Hamilton JS, Tushoski-Aleman G, Thompson G, et al
   Cumulative sum analysis after the initial learning curve for laparoscopic pancreaticoduodenectomy: Does one continue to learn?
   Surgery. 2025;186:109543.
   PubMed     Abstract available
   
   
   June 2025
10. YAMAMOTO Y, Sugiura T, Esaki M, Takahashi Y, et al
    Author's Reply to the Letter regarding our manuscript: "Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective an
    Surgery. 2025 Jun 19:109486. doi: 10.1016/j.surg.2025.109486.
    PubMed    
    
    
    
11. TAN HL, Zhao Y, Chua DW, Teo JY, et al
    Validation and modification of the PAncreatic surgery Composite Endpoint (PACE) model: A single-institution study from Southeast Asia.
    Surgery. 2025;184:109482.
    PubMed     Abstract available
    
    
    
12. SERVIN-ROJAS M, Fernandez-Del Castillo C, Mohamed M, Narayan RR, et al
    Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous neoplasms: Worrisome feature or high-risk stigmata?
    Surgery. 2025;185:109481.
    PubMed     Abstract available
    
    
    
13. XU Q, Gao Y
    Letter to the editor on "Navigating the learning curve of robotic pancreatoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise".
    Surgery. 2025 Jun 2:109464. doi: 10.1016/j.surg.2025.109464.
    PubMed    
    
    
    
14. ZHENG B, Xiao C
    Letter to the editor regarding: "Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience".
    Surgery. 2025 Jun 2:109434. doi: 10.1016/j.surg.2025.109434.
    PubMed    
    
    
    
15. KATO T, Murase Y, Baba Y, Takase K, et al
    Impact of dynamic risk stratification for postoperative pancreatic fistula using serum pancreatic amylase on the day after pancreatoduodenectomy.
    Surgery. 2025;184:109454.
    PubMed     Abstract available
    
    
    May 2025
16. NEPAL B, Gupta R, Yadav TD, Sahni N, et al
    Semisupervised home-based prehabilitation in patients undergoing pancreaticoduodenectomy: Impact on postoperative outcomes.
    Surgery. 2025;184:109455.
    PubMed     Abstract available
    
    
    
17. AGHAMALIYEV U, Werner J
    Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections.
    Surgery. 2025 May 28:109433. doi: 10.1016/j.surg.2025.109433.
    PubMed    
    
    
    
18. MUGHAL SA, Advani A
    Letter to the editor: "The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma".
    Surgery. 2025 May 28:109438. doi: 10.1016/j.surg.2025.109438.
    PubMed    
    
    
    
19. HEO D, Cardoso SA, Cardoso RP, Ibrahim NESE, et al
    Clinical implications of postoperative hyperamylasemia and postpancreatectomy acute pancreatitis after pancreatectomy: A systematic review and meta-analysis.
    Surgery. 2025;184:109443.
    PubMed     Abstract available
    
    
    
20. ZHOU X, Xie S
    Postoperative hyperlipasemia and pancreatic fistula risk: A critical reappraisal of diagnostic criteria and cohort heterogeneity.
    Surgery. 2025 May 20:109399. doi: 10.1016/j.surg.2025.109399.
    PubMed    
    
    
    
21. YANG F, Xu Y, Jin C, He H, et al
    Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center.
    Surgery. 2025;184:109412.
    PubMed     Abstract available
    
    
    
22. NIU W, Zhang Y, Wu J
    Letter to the editor on "Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy".
    Surgery. 2025 May 14:109341. doi: 10.1016/j.surg.2025.109341.
    PubMed    
    
    
    
23. HIROSE Y, Sakata J, Nomura T, Takano K, et al
    Response to letter to the editor on: "Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy".
    Surgery. 2025 May 14:109400. doi: 10.1016/j.surg.2025.109400.
    PubMed    
    
    
    
24. VALERA RJ, Hossain MS, Patnaik R, Valdivieso C, et al
    Retrospective analysis of surgical pancreatic necrosectomy outcomes in patients with and without obesity.
    Surgery. 2025;184:109410.
    PubMed     Abstract available
    
    
    
25. ZHU S, Ning C, Sun Z, Liu B, et al
    Minimal access retroperitoneal pancreatic necrosectomy for infected pancreatic necrosis: A single-center of 15 years' experience.
    Surgery. 2025;183:109392.
    PubMed     Abstract available
    
    
    
26. DOKMAK S, Karam E, Aussilhou B, Loh WL, et al
    Laparoscopic compared with open pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy.
    Surgery. 2025;181:109281.
    PubMed    
    
    
    April 2025
27. ZHANG J, Chen X
    Letter to the editor on "Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis".
    Surgery. 2025 Apr 29:109380. doi: 10.1016/j.surg.2025.109380.
    PubMed    
    
    
    
28. TURNER KM, Ahmad SA
    Large language models as clinical decision support tools: A call for careful implementation in the care of patients with pancreatic cancer.
    Surgery. 2025 Apr 25:109378. doi: 10.1016/j.surg.2025.109378.
    PubMed    
    
    
    
29. WALSH RM
    Seeking mastery in robotic pancreaticoduodenectomy: Comment on: "Navigating the learning curve of robotic pancreaticoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise".
    Surgery. 2025 Apr 22:109375. doi: 10.1016/j.surg.2025.109375.
    PubMed    
    
    
    
30. DAI Y, Fu J, Lu X, Wang Y, et al
    Differences in grade C postpancreatectomy hemorrhage with or without clinically relevant pancreatic fistula after pancreaticoduodenectomy: A retrospective cohort study.
    Surgery. 2025;183:109355.
    PubMed     Abstract available
    
    
    
31. HUANG Y, Lin J
    Comment on: "Recurrence and treatment trends of pancreatic neuroendocrine tumors".
    Surgery. 2025 Apr 7:109349. doi: 10.1016/j.surg.2025.109349.
    PubMed    
    
    
    
32. NAPOLI N, Ginesini M, Kauffmann EF, Barbarello L, et al
    Navigating the learning curve of robotic pancreatoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise.
    Surgery. 2025 Apr 2:109347. doi: 10.1016/j.surg.2025.109347.
    PubMed     Abstract available
    
    
    March 2025
33. PARK Y, Hwang DW, Lee JH, Song KB, et al
    Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience.
    Surgery. 2025;182:109331.
    PubMed     Abstract available
    
    
    
34. DUHN J, von Fritsch L, Bolm L, Braun R, et al
    Perioperative and oncologic outcomes after total pancreatectomy and pancreatoduodenectomy for pancreatic head adenocarcinoma-A propensity score-matched analysis from the German Cancer Registry Group.
    Surgery. 2025;181:109292.
    PubMed     Abstract available
    
    
    
35. AJAZ M
    Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
    Surgery. 2025 Mar 14:109320. doi: 10.1016/j.surg.2025.109320.
    PubMed    
    
    
    
36. LANCELLOTTI F, Patel A, Tsaramanidis S, Edy E, et al
    The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma.
    Surgery. 2025;181:109271.
    PubMed     Abstract available
    
    
    
37. KAISER KN, Hughes AJ, Yang AD, Mohanty S, et al
    Use of large language models as clinical decision support tools for management pancreatic adenocarcinoma using National Comprehensive Cancer Network guidelines.
    Surgery. 2025 Mar 6:109267. doi: 10.1016/j.surg.2025.109267.
    PubMed     Abstract available
    
    
    
38. CAPRETTI G, Ricci C, Langella S, Nicolini D, et al
    Outcomes after pancreatoduodenectomy and total pancreatectomy in patients with a high-risk pancreatic anastomosis: An entropy balance analysis.
    Surgery. 2025;181:109277.
    PubMed     Abstract available
    
    
    
39. PITAKTEERABUNDIT T, Fagenholz PJ, Luckhurst CM, Albutt KH, et al
    Response to letter to the editor on "Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence".
    Surgery. 2025 Mar 3:109276. doi: 10.1016/j.surg.2025.109276.
    PubMed    
    
    
    February 2025
40. AGHAMALIYEV U, Werner J
    Response to Letter to the editor: "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Feb 15:109208. doi: 10.1016/j.surg.2025.109208.
    PubMed    
    
    
    
41. SHI C, Zhang J, Wang W
    Letter to the editor on "Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence".
    Surgery. 2025 Feb 15:109213. doi: 10.1016/j.surg.2025.109213.
    PubMed    
    
    
    
42. AGHAMALIYEV U, Werner J
    Authors' reply regarding "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Feb 15:109216. doi: 10.1016/j.surg.2025.109216.
    PubMed    
    
    
    January 2025
43. OCUIN LM
    Response to: Letter to the editor on "Extended antibiotics and clinically relevant postoperative pancreatic fistula in elevated-risk patients: A single institution analysis".
    Surgery. 2025 Jan 25:109148. doi: 10.1016/j.surg.2024.109148.
    PubMed    
    
    
    
44. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Reply to letter to editor by yinfang Wu, MM about our manuscript, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2025 Jan 25:109132. doi: 10.1016/j.surg.2024.109132.
    PubMed    
    
    
    
45. MARCHEGIANI G
    Reading the tea leaves: Acute pancreatitis as a red flag in intraductal papillary mucinous neoplasms of the pancreas.
    Surgery. 2025 Jan 24:109140. doi: 10.1016/j.surg.2024.109140.
    PubMed    
    
    
    
46. YE W, Dong D, Shi X
    Letter to the editor on "Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study".
    Surgery. 2025 Jan 21:109135. doi: 10.1016/j.surg.2024.109135.
    PubMed    
    
    
    
47. HUANG S, Huang Y
    Comment on: "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Jan 18:109054. doi: 10.1016/j.surg.2024.109054.
    PubMed    
    
    
    
48. CETINKAYA E
    Letter to the editor regarding "Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study".
    Surgery. 2025 Jan 18:109130. doi: 10.1016/j.surg.2024.109130.
    PubMed    
    
    
    
49. HIROSE Y, Sakata J, Nomura T, Takano K, et al
    Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy.
    Surgery. 2025;180:109099.
    PubMed     Abstract available
    
    
    
50. SCHORN S, Fritz A, Kaissis G, Gaida MM, et al
    Neural invasion severity is a strong predictor of local recurrence in pancreatic ductal adenocarcinoma.
    Surgery. 2025;180:109018.
    PubMed     Abstract available
    
    
    
51. ROMPEN IF, Marchetti A, Levine J, Swett B, et al
    Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancer.
    Surgery. 2025;180:109114.
    PubMed     Abstract available
    
    
    
52. FU Z, Qin J, Zheng K, Liu X, et al
    Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure.
    Surgery. 2025;180:109045.
    PubMed     Abstract available
    
    
    
53. DEI H, Yokoyama Y, Mizuno T, Asahara T, et al
    Impact of the ratio of fecal short-chain fatty acids to lactic acid concentration on postoperative infectious complications after pancreaticoduodenectomy.
    Surgery. 2025;180:109040.
    PubMed     Abstract available
    
    
    
54. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Response to letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2025 Jan 3:109053. doi: 10.1016/j.surg.2024.109053.
    PubMed    
    
    
    December 2024
55. PITAKTEERABUNDIT T, Fagenholz PJ, Luckhurst CM, Albutt KH, et al
    Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence.
    Surgery. 2024 Dec 31:109038. doi: 10.1016/j.surg.2024.109038.
    PubMed     Abstract available
    
    
    
56. MURASE Y, Esaki M, Mizui T, Takamoto T, et al
    Optimal lymph node dissection area for pancreatic neuroendocrine neoplasms by tumor location, size, and grade.
    Surgery. 2024;180:109029.
    PubMed     Abstract available
    
    
    
57. TAKAMOTO T, Nara S, Ban D, Mizui T, et al
    Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes.
    Surgery. 2024;180:109026.
    PubMed     Abstract available
    
    
    
58. ZHU J
    Letter to the editor on "Extended antibiotic therapy is associated with a lower rate of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy (PD) in intermediate- and high-risk patients: A single-institution analysis".
    Surgery. 2024 Dec 27:109010. doi: 10.1016/j.surg.2024.109010.
    PubMed    
    
    
    
59. WANG C, Tian H, Shang J
    Exploration and perspectives on postoperative hyperlipasemia as a predictor of pancreatic fistula.
    Surgery. 2024 Dec 27:109025. doi: 10.1016/j.surg.2024.109025.
    PubMed    
    
    
    
60. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Reply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 20:108952. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
61. PENG L, Cao B, Wu Y
    Letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 11:108962. doi: 10.1016/j.surg.2024.108962.
    PubMed    
    
    
    
62. DADHWAL US
    Letter to the editor: Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
    Surgery. 2024 Dec 11:108961. doi: 10.1016/j.surg.2024.108961.
    PubMed    
    
    
    
63. IKENAGA N, Nakata K, Abe T, Watanabe Y, et al
    Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma.
    Surgery. 2024;178:108958.
    PubMed     Abstract available
    
    
    
64. WU YF, Zhao Q
    Letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 8:108963. doi: 10.1016/j.surg.2024.108963.
    PubMed    
    
    
    
65. SHIBAMOTO J, Ohgi K, Ashida R, Yamada M, et al
    Clinical significance of resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasis.
    Surgery. 2024 Dec 1:108925. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    November 2024
66. PIPER TB, Schaebel GH, Egeland C, Achiam MP, et al
    Fluorescence-guided pancreatic surgery: A scoping review.
    Surgery. 2024 Nov 28:108931. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
67. NOMURA S, Masui T, Muto J, Hashida K, et al
    Is distal pancreatectomy the optimal surgical procedure for pancreatic neck cancer?
    Surgery. 2024 Nov 23:108930. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
68. TSILIMIGRAS DI, Pawlik TM
    Response to letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma".
    Surgery. 2024 Nov 22:108915. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
69. KONG Y, Yang Y, Song A, Wang X, et al
    Letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma".
    Surgery. 2024 Nov 8:S0039-6060(24)00883-3. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
70. KARAM E, Ronde-Roupie C, Aussilhou B, Hentic O, et al
    Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study.
    Surgery. 2024 Nov 1:S0039-6060(24)00829-8. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    October 2024
71. KAIDA H, Miyasaka Y, Higashi D, Yamamoto R, et al
    Clinical significance of intraductal papillary mucinous neoplasms incidentally detected in patients with extrapancreatic gastrointestinal malignancies with a focus on pancreatic cancer development.
    Surgery. 2024 Oct 30:S0039-6060(24)00840-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
72. YUN D
    Letter to the editor regarding "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Oct 12:S0039-6060(24)00772-4. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
73. KATO T, Watanabe Y, Baba Y, Oshima Y, et al
    Preoperative risk-stratified analysis: External versus internal pancreatic stents in pancreatoduodenectomy.
    Surgery. 2024 Oct 8:S0039-6060(24)00715-3. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
74. AGHAMALIYEV U, Cepele G, Hofmann FO, Knoblauch M, et al
    Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections.
    Surgery. 2024 Oct 6:S0039-6060(24)00700-1. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
75. GREENSPUN BC, Foshag A, Tumati A, Marshall T, et al
    DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection.
    Surgery. 2024 Oct 4:S0039-6060(24)00694-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
76. BADER A, Landau S, Hwang J, Passman J, et al
    Recurrence and treatment trends of pancreatic neuroendocrine tumors.
    Surgery. 2024 Oct 4:S0039-6060(24)00703-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    September 2024
77. LIM JS, Lozano V, Heard J, Malo J, et al
    Redefining at-risk patients undergoiong pancreaticoduodenectomy: Impact of socioeconomic factors including Area Deprivation Index and distance traveled.
    Surgery. 2024 Sep 25:S0039-6060(24)00651-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
78. TSILIMIGRAS DI, Woldesenbet S, Chatzipanagiotou OP, Iyer S, et al
    Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma.
    Surgery. 2024 Sep 19:S0039-6060(24)00641-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    August 2024
79. ZOU Y, Xie Y, Huang J, Liang Y, et al
    Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk.
    Surgery. 2024 Aug 26:S0039-6060(24)00566-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
80. TAMBURRINO D, Arcangeli C, De Stefano F, Belfiori G, et al
    Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence.
    Surgery. 2024 Aug 26:S0039-6060(24)00544-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
81. HUANG Y
    Letter to the editor regarding: "Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer".
    Surgery. 2024 Aug 20:S0039-6060(24)00556-7. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
82. PARTELLI S, Pecorelli N
    Time to close the gap between surgical success and recovery after pancreaticoduodenectomy.
    Surgery. 2024 Aug 15:S0039-6060(24)00495-1. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    July 2024
83. AKITA H, Mukai Y, Kubo M, Takahashi H, et al
    A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer.
    Surgery. 2024 Jul 29:S0039-6060(24)00473-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
84. LI Z, Zhou L, Li M, Wang W, et al
    Early mobilization after pancreatic surgery: A randomized controlled trial.
    Surgery. 2024 Jul 24:S0039-6060(24)00450-1. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
85. ICHIDA H, Imamura H, Takahashi A, Yoshioka R, et al
    Evaluation of pancreatic morphometric parameters, exocrine function, and nutritional status and their causal relationships in long-term survivors following pancreatectomy.
    Surgery. 2024 Jul 12:S0039-6060(24)00377-5. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
86. ELLIS RJ
    Invited Commentary for "Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications".
    Surgery. 2024 Jul 11:S0039-6060(24)00452-5. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
87. LE NK, Chervu NL, Ng A, Gao Z, et al
    Center-level variation in hospitalization costs of pancreaticoduodenectomy for pancreatic cancer.
    Surgery. 2024 Jul 5:S0039-6060(24)00369-6. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
88. OCUIN LM, Hardacre JM
    Extended antibiotics and clinically relevant postoperative pancreatic fistula in elevated-risk patients: A letter in response to "Hidden determinants of the duration of antibiotics after pancreaticoduodenectomy".
    Surgery. 2024 Jul 4:S0039-6060(24)00382-9. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    June 2024
89. BASSI C, Marchegiani G, Dervenis C, Sarr M, et al
    Corrigendum to "The 2016 update of the International Study Group (ISGPF) definition and grading of postoperative pancreatic fistula: eleven years after." Surgery 2017. Mar; 161 (3):584-591. Epub Dec 28, 2016.
    Surgery. 2024 Jun 25:S0039-6060(24)00374-X. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
90. YAMAMOTO Y, Sugiura T, Esaki M, Takahashi Y, et al
    Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis.
    Surgery. 2024 Jun 21:S0039-6060(24)00308-8. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
91. MUNIR MM, Rashid Z, Endo Y, Dillhoff M, et al
    Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma.
    Surgery. 2024 Jun 17:S0039-6060(24)00309-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
92. KATO T, Watanabe Y, Oshima Y, Takase K, et al
    Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study.
    Surgery. 2024 Jun 14:S0039-6060(24)00298-8. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    May 2024
93. ADDEO P, de Mathelin P, Doussot A, Durin T, et al
    Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.
    Surgery. 2024 May 25:S0039-6060(24)00229-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
94. HARRISON J, Dua MM, Kastrinakis WV, Fagenholz PJ, et al
    "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy.
    Surgery. 2024 May 24:S0039-6060(24)00270-8. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
95. PETROVA E, Mazzella E, Wellner U, Keck T, et al
    Monopolar electrocautery versus scalpel for pancreatic neck transection during open pancreatoduodenectomy: A retrospective, registry-based study.
    Surgery. 2024 May 23:S0039-6060(24)00188-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
96. STEFFANI M, Jager C, Huser N, Friess H, et al
    Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
    Surgery. 2024 May 19:S0039-6060(24)00190-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
97. YANG Y, Li Z, Du Z
    Letter to the editor on "The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation".
    Surgery. 2024 May 16:S0039-6060(24)00183-1. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
98. MARIQUE L, Codjia T, Dembinski J, Dokmak S, et al
    Retromesenteric omental flap as arterial coverage in pancreaticoduodenectomy: A novel technique to prevent postpancreatectomy hemorrhage.
    Surgery. 2024 May 16:S0039-6060(24)00204-6. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
99. MIZUNO Y, Yokoyama Y, Nakajima H, Inoue T, et al
    The impact of goal-directed prehabilitation therapy on functional capacity in patients undergoing hepatobiliary and pancreatic surgery: A randomized clinical trial.
    Surgery. 2024 May 15:S0039-6060(24)00272-1. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
100. HUGHES DLL, Hughes A, Gordon-Weeks AN, Silva MA, et al
     Continuous drain irrigation as a risk mitigation strategy for postoperative pancreatic fistula: a meta-analysis.
     Surgery. 2024 May 10:S0039-6060(24)00192-2. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     
101. ITO H
     Hidden determinants of the duration of antibiotics after pancreaticoduodenectomy.
     Surgery. 2024 May 7:S0039-6060(24)00182-X. doi: 10.1016/j.surg.2024.
     PubMed    
     
     
     April 2024
102. HOUSE MG
     Invited commentary for "Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer.
     Surgery. 2024 Apr 15:S0039-6060(24)00147-8. doi: 10.1016/j.surg.2024.
     PubMed    
     
     
     
103. MANZELLA A, Ecker BL, Eskander MF, Grandhi MS, et al
     Operative trends for pancreatic and hepatic malignancies during the COVID-19 pandemic.
     Surgery. 2024 Apr 6:S0039-6060(24)00125-9. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     March 2024
104. SRIENC MK, Donahue TR
     Carnitine palmitoyltransferase 1B mediates gemcitabine resistance in pancreatic cancer.
     Surgery. 2024 Mar 25:S0039-6060(24)00116-8. doi: 10.1016/j.surg.2024.
     PubMed    
     
     
     
105. MAEHIRA H, Tani M, Mori H, Ichikawa D, et al
     Long-term outcomes after spleen-preserving distal pancreatectomy with splenic vessels preservation or resection: A nationwide survey of the Japanese Society of Pancreatic Surgery.
     Surgery. 2024 Mar 21:S0039-6060(24)00053-9. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     
106. WISMANS LV, Suurmeijer JA, van Dongen JC, Bonsing BA, et al
     Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis.
     Surgery. 2024 Mar 5:S0039-6060(24)00055-2. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     February 2024
107. WARD EP, Vincent-Sheldon S, Tolat P, Kulkarni N, et al
     Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy.
     Surgery. 2024 Feb 26:S0039-6060(24)00041-2. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     
108. NING C, Sun Z, Shen D, Lin C, et al
     Is Contemporary Open Pancreatic Necrosectomy Still Useful In The Minimally Invasive Era?
     Surgery. 2024 Feb 19:S0039-6060(24)00046-1. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     
109. SHIMIZU T, Maeda S, Link J, Deranteriassian A, et al
     Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis.
     Surgery. 2024 Feb 15:S0039-6060(24)00008-4. doi: 10.1016/j.surg.2024.
     PubMed     Abstract available
     
     
     
110. STAUFFER JA, Hyman D, Porrazzo G, Tice M, et al
     A propensity score-matched analysis of laparoscopic versus open pancreaticoduodenectomy: Is there value to a laparoscopic approach?
     Surgery. 2024 Feb 1:S0039-6060(23)00965-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
111. FARAH E, Al Abbas A, Abreu AA, Cheng M, et al
     Minimally invasive pancreaticoduodenectomy: A favorable approach for frail patients with pancreatic cancer.
     Surgery. 2024 Feb 1:S0039-6060(23)00966-2. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     January 2024
112. TUERHONG A, Xu J, Wang W, Shi S, et al
     CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.
     Surgery. 2024 Jan 31:S0039-6060(23)00963-7. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
113. FU Z, Gao S, Wu X, Qin J, et al
     Hand-sewn gastrojejunal anastomosis reduces delayed gastric emptying after pancreaticoduodenectomy: A single-center retrospective clinical study of 1,077 consecutive patients.
     Surgery. 2024 Jan 29:S0039-6060(23)00905-4. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
114. ATYAH MM, Huang J, Yang Z
     Intraoperative segmental pancreatic occlusion and insulin assay combination optimizes the localization of lesions and confirmation of complete resection in pancreatic hypoglycemia patients.
     Surgery. 2024 Jan 23:S0039-6060(23)00906-6. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
115. NIESSEN A, Klaiber U, Lewosinska M, Nickel F, et al
     Portal vein resection in pancreatic neuroendocrine neoplasms.
     Surgery. 2024 Jan 22:S0039-6060(23)00964-9. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     December 2023
116. EVANS D, Ghassemi N, Hajibandeh S, Hajibandeh S, et al
     Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer.
     Surgery. 2023 Dec 29:S0039-6060(23)00893-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
117. PETRUCH N, Servin Rojas M, Lillemoe KD, Castillo CF, et al
     The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries.
     Surgery. 2023 Dec 12:S0039-6060(23)00844-9. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
118. JEUNE F, Collard M, Augustin J, Guedj N, et al
     Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
     Surgery. 2023 Dec 8:S0039-6060(23)00818-8. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
119. YAMGUCHI T, Mori K, Kojima Y, Hasegawa T, et al
     Efficacy of perioperative oral care management in the prevention of surgical complications in 503 patients after pancreaticoduodenectomy for resectable malignant tumor: A multicenter retrospective analysis using propensity score matching.
     Surgery. 2023 Dec 6:S0039-6060(23)00848-6. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
120. VON EHRLICH-TREUENSTATT VH, Guenther M, Ilmer M, Knoblauch MM, et al
     Preoperative ultrasound elastography for postoperative pancreatic fistula prediction after pancreatoduodenectomy: A prospective study.
     Surgery. 2023 Dec 2:S0039-6060(23)00828-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     November 2023
121. MUADDI H, Salehinejad H, Thiels CA
     Persistent challenges in pancreatic surgery: Postoperative pancreatic fistula prediction in the machine learning era-Response to: Machine learning versus logistic regression for the prediction of complications after pancreaticoduodenectomy.
     Surgery. 2023 Nov 30:S0039-6060(23)00836-X. doi: 10.1016/j.surg.2023.
     PubMed    
     
     
     
122. KUBO H, Ohgi K, Ohike N, Norose T, et al
     Tumor vascularity on contrast-enhanced computed tomography as a predictive marker of metastatic potential for small nonfunctioning pancreatic neuroendocrine tumors.
     Surgery. 2023 Nov 29:S0039-6060(23)00809-7. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
123. SERVIN-ROJAS M, Fong ZV, Fernandez-Del Castillo C, Ferrone CR, et al
     Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma.
     Surgery. 2023 Nov 8:S0039-6060(23)00711-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
124. OCUIN LM, Loftus A, Elshami M, Hue JJ, et al
     Extended antibiotic therapy is associated with a lower rate of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy in intermediate- and high-risk patients: A single-institution analysis.
     Surgery. 2023 Nov 6:S0039-6060(23)00719-5. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     October 2023
125. PARK SS, Verm RA, Abdelsattar ZM, Kramer S, et al
     Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
     Surgery. 2023 Oct 18:S0039-6060(23)00608-6. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
126. STEPHENS K, Philips PP, Egger ME, Scoggins CR, et al
     Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer.
     Surgery. 2023 Oct 16:S0039-6060(23)00609-8. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
127. XU Y, Jin C, Fu D, Yang F, et al
     External validation of fistula risk scores for postoperative pancreatic fistula after distal pancreatectomy.
     Surgery. 2023 Oct 10:S0039-6060(23)00588-3. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     September 2023
128. SALVIA R, Burelli A, Nepi A, Caravati A, et al
     Pancreatic cystic neoplasms: Still high rates of preoperative misdiagnosis in the guidelines and endoscopic ultrasound era.
     Surgery. 2023 Sep 25:S0039-6060(23)00444-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     July 2023
129. FLEMING AM, Hendrick LE, Glazer ES, Murphy AJ, et al
     Pancreatic carcinosarcoma: An orthogonal analysis.
     Surgery. 2023 Jul 29:S0039-6060(23)00423-3. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
130. AHMAD SB, Hodges JC, Nassour I, Casciani F, et al
     The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.
     Surgery. 2023 Jul 17:S0039-6060(23)00392-6. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
131. GROEN JV, Michiels N, Besselink MG, Bosscha K, et al
     Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study.
     Surgery. 2023 Jul 13:S0039-6060(23)00395-1. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     June 2023
132. CAPACIO BA, Shankara Narayanan JS, Vicente DA, Liu Y, et al
     Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model.
     Surgery. 2023 Jun 28:S0039-6060(23)00306-9. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
133. STUART CM, Kirsch MJ, Zhuang Y, Meguid CL, et al
     Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer.
     Surgery. 2023 Jun 28:S0039-6060(23)00303-3. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
134. CHO NY, Chervu NL, Sakowitz S, Verma A, et al
     Effect of surgical timing on outcomes after cholecystectomy for mild gallstone pancreatitis.
     Surgery. 2023 Jun 22:S0039-6060(23)00304-5. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
135. HONSELMANN KC, Elser Y, Boeckmann T, Bolm L, et al
     Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
     Surgery. 2023 Jun 20:S0039-6060(23)00248-9. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
136. ALHULAILI ZM, Linnemann RJ, Dascau L, Pleijhuis RG, et al
     A Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis analysis to evaluate the quality of reporting of postoperative pancreatic fistula prediction models after pancreatoduodenectomy: A systematic review.
     Surgery. 2023 Jun 7:S0039-6060(23)00264-7. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     May 2023
137. KUBO H, Ohgi K, Ohike N, Tone K, et al
     Corrigendum to Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer: [Surgery. 2022;172(6):1776-81, DOI: 10.1016/j.surg.2022.09.025].
     Surgery. 2023 May 30:S0039-6060(23)00268-4. doi: 10.1016/j.surg.2023.
     PubMed    
     
     
     
138. ROY M, Kocher HM
     Pancreatitis sepsis: Evolution and principles in the management of necrotizing pancreatitis.
     Surgery. 2023 May 15:S0039-6060(23)00199-X. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     April 2023
139. KATOU S, Wenning AS, Aeschbacher P, Morgul H, et al
     Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
     Surgery. 2023 Apr 28:S0039-6060(23)00129-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
140. SUGUMAR K, Gendi S, Quereshy HA, Gupta S, et al
     An analysis of time to treatment in patients with pancreatic adenocarcinoma.
     Surgery. 2023 Apr 25:S0039-6060(23)00157-5. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     March 2023
141. MIZUNUMA K, Kurashima Y, Poudel S, Watanabe Y, et al
     Surgical skills assessment of pancreaticojejunostomy using a simulator may predict patient outcomes: A multicenter prospective observational study.
     Surgery. 2023 Mar 30:S0039-6060(23)00116-2. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
142. BANNONE E, Marchegiani G, Zamboni GA, Maris BM, et al
     Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features.
     Surgery. 2023 Mar 17:S0039-6060(23)00060-0. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
143. CUCCHETTI A, Djulbegovic B, Crippa S, Hozo I, et al
     Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer.
     Surgery. 2023 Mar 15:S0039-6060(23)00042-9. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     February 2023
144. SUURMEIJER JA, Emmen AM, Bonsing BA, Busch OR, et al
     Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy: "Less is more".
     Surgery. 2023 Feb 27:S0039-6060(23)00004-1. doi: 10.1016/j.surg.2023.
     PubMed     Abstract available
     
     
     
145. HEWITT DB, Wolfgang CL
     Invited commentary for the article "Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?".
     Surgery. 2023 Feb 26:S0039-6060(23)00046-6. doi: 10.1016/j.surg.2023.
     PubMed    
     
     
     
146. RAZA SS, Nutu A, Powell-Brett S, Marchetti A, et al
     Early postoperative risk stratification in patients with pancreatic fistula after pancreaticoduodenectomy.
     Surgery. 2023;173:492-500.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.